Macular degeneration, also known as age-related macular degeneration (AMD or ARMD), is a medical condition which may result in blurred or no vision in the center of the visual field. Early on there are often no symptoms. Over time, however, some people experience a gradual worsening of vision that may affect one or both eyes. While it does not result in complete blindness, loss of central vision can make it hard to recognize faces, drive, read, or perform other activities of daily life. Visual hallucinations may also occur but these do not represent a mental illness.
This report contains market size and forecasts of Macular Degeneration Treatment in Global, including the following market information:
Global Macular Degeneration Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Macular Degeneration Treatment market was valued at 6123.2 million in 2021 and is projected to reach US$ 7761.6 million by 2028, at a CAGR of 3.4% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Lucentis Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Macular Degeneration Treatment include Bausch Health Companies, Allergan, Novartis, Pfizer, Bayer, Roche, Sanofi, Santen Pharmaceuticals and Regeneron Pharmaceuticals and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Macular Degeneration Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Macular Degeneration Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Macular Degeneration Treatment Market Segment Percentages, by Type, 2021 (%)
Lucentis
Eylea
Avastin
Others
Global Macular Degeneration Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Macular Degeneration Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals
Eye Clinics
Others
Global Macular Degeneration Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Macular Degeneration Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Macular Degeneration Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Macular Degeneration Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bausch Health Companies
Allergan
Novartis
Pfizer
Bayer
Roche
Sanofi
Santen Pharmaceuticals
Regeneron Pharmaceuticals
Kanghong Pharma